Nanospectra Biosciences, Inc.

Nanospectra Biosciences, Inc.

Nanospectra developing AuroLase™ therapy, a medical device which incorporates a new class of particles to selectively destroy solid tumors.  These AuroShell™ particles (also known as nanoshells) are delivered systemically and then activated by a near-infrared laser, resulting in the thermal destruction of the tumor and the blood vessels supplying them without significant damage to healthy tissue.  While AuroShell particles can be used to destroy nearly all solid tumors, we plan to conduct our first clinical trial in 2006 in patients with head and neck cancer.

Source: Nanospectra Biosciences, Inc.

Jennifer Khorchani
8285 El Rio Street, Suite 150
Houston Texas 77054
US
(713) 842-2720
Category: graduate companies | Sub Category: nanotechnology